Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02360306 · ClinicalTrials.gov registry record · NA

The Analysis of the EBUS Scope as a Hybrid Bronchoscope

A NA study of Lymphadenopathy, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
62
Enrollment target
1
Study location

NCT02360306: Completed NA study of Lymphadenopathy, sponsored by Johns Hopkins University.

NCT02360306 is a NA study of Lymphadenopathy that has completed, run by Johns Hopkins University. The registered enrollment target is 62 participants, below the 69-participant average among 5 other Lymphadenopathy trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02360306, a NA study of Lymphadenopathy, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
62 participants
Enrollment target
1
Study location

Study Summary

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used in the diagnosis of mediastinal and hilar adenopathy as well as in staging in lung cancer patients. Many studies have confirmed the utility of EBUS-TBNA with high sensitivity, specificity, and accuracy for the diagnosis of mediastinal and hilar adenopathy. 1-3 Less well reported has been the use of the EBUS bronchoscope to perform other procedures such as transbronchial biopsy (TBBx), endobronchial biopsy (EBBx), bronchoalveolar lavage (BAL) and airway brushings. While not well reported in the medical literature, anecdotal evidence supports these practices. The investigators propose a methodological evaluation of the full spectrum of procedures that have been performed and that are possible using an EBUS bronchoscope.

Primary Outcome

Procedures able to be performed succesfully by Hybrid EBUS in comparison to Conventional EBUS. This will be assessed using a case report form that includes a checklist of various procedures (e.g. TBNA, transbronchial forcep biopsy)

Conditions Studied

Interventions

  • PROCEDURE Endobronchial Ultrasound

Study Locations (1)

Maryland

  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2013-01
Est. Completion 2014-01
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT02360306 record still lists

NCT02360306 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 69-participant average among 5 other Lymphadenopathy trials with a reported enrollment target (10% lower).

The record links to 1 condition, with Lymphadenopathy appearing as the primary indexed condition, and to 1 intervention - of which Endobronchial Ultrasound is the first listed.

NCT02360306 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT02360306 about?

NCT02360306 is a clinical study titled "The Analysis of the EBUS Scope as a Hybrid Bronchoscope". Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used in the diagnosis of mediastinal and hilar adenopathy as well as in staging in lung cancer patients. Many studies have confirmed the utility of EBUS-TBNA with high sensitivity, specificity, and accuracy for th...

What is the current status of trial NCT02360306?

This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2013-01. Estimated completion is 2014-01.

What conditions does trial NCT02360306 study?

This clinical trial studies the following conditions: Lymphadenopathy.

What interventions are being tested in trial NCT02360306?

The interventions under investigation include: Endobronchial Ultrasound (PROCEDURE).

Who is sponsoring clinical trial NCT02360306?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02360306 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lymphadenopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03231150 · 62 participants · NA

    Plantar Fasciitis Randomized Clinical Control Trial

  • NCT03458676 · 62 participants · NA

    Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

  • NCT03596086 · 62 participants · Phase 1

    HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

  • NCT03603405 · 62 participants · Phase 1

    HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02360306, the US trial registry maintained by the National Library of Medicine. NCT02360306 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.